Combined irradiation and chemotherapy for sarcomas of the pelvis in females.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010386:Pelvic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D010502:Perineum; D011867:Radioisotope Teletherapy; D011882:Radiotherapy, High-Energy; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D012509:Sarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014625:Vaginal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide